Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-01-18
1997-05-06
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 551, A61K 3170
Patent
active
056271620
ABSTRACT:
The present invention relates to methods to control undesired cell proliferation of remnant cells following surgery, by applying an effective amount of at least one proteoglycan-type substrate adhesion molecule (SAM) to the site of surgery. SAMs, in particular chondroitin sulfate, hyaluronic acid, and non-toxic, pharmaceutically acceptable salts thereof, alone or in a composition form, are typically used to prevent or inhibit growth of lens-related cells in a lens capsule after surgical removal of the lens, or to prevent proliferative vitreoretinopathy following retinal reattachment procedure performed with or without vitrectomy.
REFERENCES:
patent: 4039662 (1977-08-01), Hecht et al.
patent: 4328803 (1982-05-01), Pape
patent: 4432751 (1984-02-01), Emery et al.
patent: 4486416 (1984-12-01), Soll et al.
patent: 4657930 (1987-04-01), Emery et al.
patent: 4665089 (1987-05-01), Siezen et al.
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 4778815 (1988-10-01), Cash et al.
patent: 4778828 (1988-10-01), Palmai et al.
patent: 4797422 (1989-01-01), Testa et al.
patent: 4826872 (1989-05-01), Terao et al.
patent: 4871350 (1989-10-01), Lam et al.
patent: 4886786 (1989-12-01), Lindstrom et al.
patent: 4965253 (1990-10-01), Goldberg et al.
Wedrich, A., et al Ophthalmologica, vol. 205(3), 125-30.1992.
Wedrich, A., et al. J.Cataract Refract. Surg., vol. 18(5), 500-5. Sep. 1992.
Ruusuvaara, P., et al. Acta Ophthalmol. (Denmark) vol. 68(6), 721-7, Dec. 1990.
Glaser, D.B., et al. Arch. Opthalmol. (U.S.) vol. 104(12), 1819-1824, Dec. 1986.
Pape, L.G. J. Am. Intraocular Implant. Soc. vol. 6(4), 342-3. Oct. 1980.
Gibson, Chemical Abstracts, vol. 108(4), 1988, No. 26987a.
Kita, Chemical Abstracts, vol. 113(2), 1990, No. 12153s.
Cole et al., International Surgery 59, 242 (1968).
Nissen et al., British J. Ophthal. 65, 63 (1981).
Roberts et al., Investigative Ophthlamology & Visual Science 25, 746 (1984).
Stark et al., Ophthlamology 92, 209 (1985).
Shizohara, Chemical Abstracts, vol. 106(14), 1987, No. 107919r.
Ling et al, Chemical Abstracts, vol. 108(2), 1988, No. 11056x.
Gwon Arlene E.
Hagemeier Charles J.
LandOfFree
Methods and means for control of proliferation of remnant cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and means for control of proliferation of remnant cells , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and means for control of proliferation of remnant cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2132705